Association Between Prior Aspirin Use and Acute Respiratory Distress Syndrome Incidence in At-Risk Patients: A Systematic Review and Meta-Analysis

BackgroundRecent studies have shown that prior antiplatelet drug use could ameliorate the risk and mortality of acute respiratory distress syndrome (ARDS). However, the connection between prior acetylsalicylic acid (aspirin) use and the risk of ARDS is unknown. Our primary objective was to perform a...

Full description

Bibliographic Details
Main Authors: Huoyan Liang, Xianfei Ding, Hongyi Li, Lifeng Li, Tongwen Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-05-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.00738/full
id doaj-ecf8aec5bf3e4c4f847487ca1578596b
record_format Article
spelling doaj-ecf8aec5bf3e4c4f847487ca1578596b2020-11-25T02:48:21ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-05-011110.3389/fphar.2020.00738512142Association Between Prior Aspirin Use and Acute Respiratory Distress Syndrome Incidence in At-Risk Patients: A Systematic Review and Meta-AnalysisHuoyan Liang0Xianfei Ding1Hongyi Li2Lifeng Li3Tongwen Sun4General ICU, First Affiliated Hospital of Zhengzhou University, Henan Key Laboratory of Critical Care Medicine, Zhengzhou, ChinaGeneral ICU, First Affiliated Hospital of Zhengzhou University, Henan Key Laboratory of Critical Care Medicine, Zhengzhou, ChinaGeneral ICU, First Affiliated Hospital of Zhengzhou University, Henan Key Laboratory of Critical Care Medicine, Zhengzhou, ChinaCancer Centre, First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaGeneral ICU, First Affiliated Hospital of Zhengzhou University, Henan Key Laboratory of Critical Care Medicine, Zhengzhou, ChinaBackgroundRecent studies have shown that prior antiplatelet drug use could ameliorate the risk and mortality of acute respiratory distress syndrome (ARDS). However, the connection between prior acetylsalicylic acid (aspirin) use and the risk of ARDS is unknown. Our primary objective was to perform a meta-analysis on the currently available studies to assess the association between aspirin use prior to ARDS onset and ARDS incidence in at-risk patients.MethodsTwo investigators separately searched four research databases: MEDLINE, EMBASE, Cochrane Library, and Web of Science for relevant articles from the earliest available data through to July 14, 2019. In this paper, we performed a meta-analysis of the fixed effects model using the inverse variance-weighted average method to calculate the pooled odds ratios (ORs) and 95% confidence intervals (CIs). The primary outcome was risk of ARDS, and the secondary outcome was the hospital mortality of at-risk patients.ResultsThis article included seven studies altogether, enrolling 6,764 at-risk patients. Our meta-analysis revealed that, compared to non-aspirin use, prior aspirin use was linked with a significantly lower incidence of ARDS in at-risk patients (OR, 0.78; 95% CI, 0.64–0.96; P = 0.018) with low statistical heterogeneity (I2 = 1.7%). Additionally, difference between prior aspirin use and non-aspirin use was not remarkable for hospital mortality in at-risk patients (OR, 0.88; 95% CI, 0.73–1.07; P = 0.204), and this analysis did not involve statistical heterogeneity (I2 = 0%).ConclusionsThis article indicates an association between prior aspirin use and a lower incidence of ARDS in at-risk patients, suggesting that aspirin use could potentially lower the risk of ARDS, and the investigation of such an effect is an interesting area for future clinical studies.https://www.frontiersin.org/article/10.3389/fphar.2020.00738/fullaspirinacute respiratory distress syndromeat-risksystematic reviewmeta-analysis
collection DOAJ
language English
format Article
sources DOAJ
author Huoyan Liang
Xianfei Ding
Hongyi Li
Lifeng Li
Tongwen Sun
spellingShingle Huoyan Liang
Xianfei Ding
Hongyi Li
Lifeng Li
Tongwen Sun
Association Between Prior Aspirin Use and Acute Respiratory Distress Syndrome Incidence in At-Risk Patients: A Systematic Review and Meta-Analysis
Frontiers in Pharmacology
aspirin
acute respiratory distress syndrome
at-risk
systematic review
meta-analysis
author_facet Huoyan Liang
Xianfei Ding
Hongyi Li
Lifeng Li
Tongwen Sun
author_sort Huoyan Liang
title Association Between Prior Aspirin Use and Acute Respiratory Distress Syndrome Incidence in At-Risk Patients: A Systematic Review and Meta-Analysis
title_short Association Between Prior Aspirin Use and Acute Respiratory Distress Syndrome Incidence in At-Risk Patients: A Systematic Review and Meta-Analysis
title_full Association Between Prior Aspirin Use and Acute Respiratory Distress Syndrome Incidence in At-Risk Patients: A Systematic Review and Meta-Analysis
title_fullStr Association Between Prior Aspirin Use and Acute Respiratory Distress Syndrome Incidence in At-Risk Patients: A Systematic Review and Meta-Analysis
title_full_unstemmed Association Between Prior Aspirin Use and Acute Respiratory Distress Syndrome Incidence in At-Risk Patients: A Systematic Review and Meta-Analysis
title_sort association between prior aspirin use and acute respiratory distress syndrome incidence in at-risk patients: a systematic review and meta-analysis
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2020-05-01
description BackgroundRecent studies have shown that prior antiplatelet drug use could ameliorate the risk and mortality of acute respiratory distress syndrome (ARDS). However, the connection between prior acetylsalicylic acid (aspirin) use and the risk of ARDS is unknown. Our primary objective was to perform a meta-analysis on the currently available studies to assess the association between aspirin use prior to ARDS onset and ARDS incidence in at-risk patients.MethodsTwo investigators separately searched four research databases: MEDLINE, EMBASE, Cochrane Library, and Web of Science for relevant articles from the earliest available data through to July 14, 2019. In this paper, we performed a meta-analysis of the fixed effects model using the inverse variance-weighted average method to calculate the pooled odds ratios (ORs) and 95% confidence intervals (CIs). The primary outcome was risk of ARDS, and the secondary outcome was the hospital mortality of at-risk patients.ResultsThis article included seven studies altogether, enrolling 6,764 at-risk patients. Our meta-analysis revealed that, compared to non-aspirin use, prior aspirin use was linked with a significantly lower incidence of ARDS in at-risk patients (OR, 0.78; 95% CI, 0.64–0.96; P = 0.018) with low statistical heterogeneity (I2 = 1.7%). Additionally, difference between prior aspirin use and non-aspirin use was not remarkable for hospital mortality in at-risk patients (OR, 0.88; 95% CI, 0.73–1.07; P = 0.204), and this analysis did not involve statistical heterogeneity (I2 = 0%).ConclusionsThis article indicates an association between prior aspirin use and a lower incidence of ARDS in at-risk patients, suggesting that aspirin use could potentially lower the risk of ARDS, and the investigation of such an effect is an interesting area for future clinical studies.
topic aspirin
acute respiratory distress syndrome
at-risk
systematic review
meta-analysis
url https://www.frontiersin.org/article/10.3389/fphar.2020.00738/full
work_keys_str_mv AT huoyanliang associationbetweenprioraspirinuseandacuterespiratorydistresssyndromeincidenceinatriskpatientsasystematicreviewandmetaanalysis
AT xianfeiding associationbetweenprioraspirinuseandacuterespiratorydistresssyndromeincidenceinatriskpatientsasystematicreviewandmetaanalysis
AT hongyili associationbetweenprioraspirinuseandacuterespiratorydistresssyndromeincidenceinatriskpatientsasystematicreviewandmetaanalysis
AT lifengli associationbetweenprioraspirinuseandacuterespiratorydistresssyndromeincidenceinatriskpatientsasystematicreviewandmetaanalysis
AT tongwensun associationbetweenprioraspirinuseandacuterespiratorydistresssyndromeincidenceinatriskpatientsasystematicreviewandmetaanalysis
_version_ 1724748412631384064